Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L3SP
|
|||
| Drug Name |
MVA-BN Filo
|
|||
| Indication | Ebola virus infection [ICD-11: 1D60.0] | Phase 3 | [1] | |
| Company |
Bavarian NordicMorrisville, NCJanssen Vaccines and Prevention Leiden, Netherlands
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02661464) Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.